Patent Assignment
Reel/Frame 041244/0319
Change of Name
Recorded: 2017-01-04
Pages: 4
Assignor
ALDEXA THERAPEUTICS, INC.
Executed: 2014-03-17
Assignee
ALDEYRA THERAPEUTICS, INC.
131 HARTWELL AVENUE, SUITE 320, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Compositions and Methods of Treating Retinal Disease
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 4, 2017
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 040837/0806 →
Change of Name
Jan 4, 2017
From: NEURON SYSTEMS, INC.
To: ALDEXA THERAPEUTICS, INC.
Reel/Frame 041244/0317 →
Change of Address
Jan 4, 2017
From: NEURON SYSTEMS, INC.
To: NEURON SYSTEMS, INC.
Reel/Frame 041251/0216 →
Security Interest
Nov 13, 2017
From: ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC.)
To: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
Reel/Frame 044106/0800 →
Release of Security Interest
Dec 5, 2018
From: PACIFIC WESTERN BANK (SUCCESSOR BY MERGER TO SQUARE 1 BANK)
To: ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC. F/K/A NEURON SYSTEMS, INC.)
Reel/Frame 047683/0482 →